KEGG   DRUG: Afamitresgene autoleucel
Entry
D12951                      Drug                                   
Name
Afamitresgene autoleucel (USAN/INN);
Tecelra (TN);
Tecelra (TN)
Product
TECELRA (Adaptimmune LLC)
Remark
Product: D12951<US>
Efficacy
Antineoplastic
  Disease
Synovial sarcoma (HLA-A*02 restricted) [DS:H00050]
  Type
Cellular therapy product, TCR-T cell therapy
Target
MAGEA4 [HSA:4103] [KO:K24127]
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Immune system
    MAGEA4
     D12951  Afamitresgene autoleucel (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D12951
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12951
Other DBs
PubChem: 500141101
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system